A former Sun Pharmaceuticals national account director filed a retaliation lawsuit against the drugmaker, claiming she was fired for objecting to off-label marketing.
Endo International is searching for a new CEO after Paul Campanelli said this week that he intends to retire, according to the Philadelphia Business Journal.
Below are 16 legal actions involving members of the drug supply chain, including pharmaceutical manufacturers, pharmacies, pharmacists, patient charities, distributors and executives, reported by Becker's Hospital Review in the last two months:
Walgreens handled about 20 percent of oxycodone and hydrocodone pills in U.S. pharmacies during the height of the opioid crisis, according to The Washington Post.
The Trump administration filed a lawsuit against Gilead Nov. 6, accusing the drugmaker of making billions of dollars from taxpayer-funded research without paying taxpayers back.
HealthPartners, a nonprofit healthcare provider and insurer in Bloomington, Minn., will close all of its retail pharmacies and shut down its mail-order pharmacy operations next year, according to the Pioneer Press.
Several advocacy groups filed a petition Nov. 5 urging the CDC to acknowledge that it accepts commercial support and has financial relationships with drugmakers.
A group of 35 biotech associations sent a letter to Sens. Chuck Grassley (R-Iowa) and Ron Wyden (D-Ore.) warning that their plan to redesign Medicare Part D could have a "chilling effect" on specialty drug innovation.
The HHS Office of Inspector General found during an audit to determine whether Medicare Part D sponsors correctly reported pharmacy fees that Geisinger didn't report its point-of-sale fees for three years.
